Clinical Trial Update: A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating the obesity drug candidate RGT001-075 in adults with obesity or overweight and weigh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• RGT001-075

Snippet

Sponsor: Regor Pharmaceuticals Inc. | Conditions: Obesity | Phase 2 | Status: COMPLETED